The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 leaps to five-month high on vaccine optimism

Wed, 11th Nov 2020 09:31

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Flutter, BAE Systems jump on raising profit forecast

* Workspace slips on first-half loss, dividend push back

* FTSE 100 up 1.4%, FTSE 250 adds 1.6%
(Updates to close)

By Devik Jain

Nov 11 (Reuters) - London stocks jumped on Wednesday,
logging nearly 8% gains this week, as optimism about an
effective COVID-19 vaccine offset concerns over surging
coronavirus cases and a deadlock in Brexit trade talks with the
European Union.

The blue-chip FTSE 100 index closed up 1.4%,
touching its highest level since June 10, with British Airways
owner IAG rising 8% after Goldman Sachs upgraded the
stock to 'buy'.

A weaker sterling also boosted dollar earners such as
AstraZeneca Plc, British American Tobacco Plc
and Unilever Plc and HSBC Holdings Plc.

The domestically focused mid-cap FTSE 250 ended 1.6%
higher, boosted by financial and real estate
stocks.

"This week's news on a vaccine, while welcome, does not
change the fact that France, Germany and the UK are still in the
middle of partial economic lockdowns," Michael Hewson, chief
market analyst at CMC Markets, wrote in a note.

"However, for now markets appear content to ignore this and
are focusing on the potential green pastures of a post-pandemic
world, with a workable vaccine."

After falling nearly 5% in October, the FTSE 100 is up more
than 14% this month, outperforming its U.S. and European peers
as a slew of stimulus measures and positive vaccine data
supported hopes of a sooner-than-expected economic recovery.

England's Deputy Chief Medical Officer Jonathan Van-Tam said
the country was ready to roll out a vaccine once regulators
approved it as safe, as it grapples with more than 61,000
COVID-related deaths, Europe's highest toll.

Brexit news also drew attention with Prime Minister Boris
Johnson saying he was hopeful a trade deal with the EU could
still be agreed, but that Brussels needed to understand
Britain's priorities.

Workspace Group slipped 2.5%, after it swung to a
first-half loss and deferred a decision on full-year dividend.

Online betting group Flutter Entertainment and
defence company BAE Systems Plc jumped 5% and 2.5%
respectively, after they raised their annual earnings forecast.
(Reporting by Devik Jain in Bengaluru; Editing by Bernard Orr,
Anil D'Silva and Mark Heinrich)

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.